A Vaccine against Ebola Virus.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32243796.
- Also identified by DOI 10.1016/j.cell.2020.03.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ervebo is the first licensed vaccine for prevention of Ebola virus disease. The vaccine, originally developed by the Public Health Agency of Canada, is delivered in a single 1 mL dose and has been delivered to >200,000 people in an ongoing 2018-2020 outbreak of disease. To view this Bench to Bedside, open or download the PDF.
Medical subject headings
- Antibodies, Viral
- Disease Outbreaks
- Ebola Vaccines
- Hemorrhagic Fever, Ebola
- Mass Vaccination